ArticleCancer medicine2013

Isocitrate dehydrogenase 2 mutation is a frequent event in osteosarcoma detected by a multi-specific monoclonal antibody MsMab-1.

Xing Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.